Response to BM&FBOVESPA‘s 3210/2015-SAE letter

São Paulo, October 26, 2015 – Linx S.A. (BM&FBovespa: LINX3) (“CompanyLinx“) in attention to the BM&FBOVESPA‘s 3210/2015-SAE letter, dated from October 23, 2015 and received by the Company on the same date, by which BM&FBOVESPA requests the Company‘s clarification about the recent fluctuations in its stock and in relation to the increase in the number of trades and trading volume, announces that it is not aware of any fact that could justify the changes in the Company‘s stock at the BM&FBOVESPA trading sessions held between 9 and 23 October, 2015.

Linx clarifies that the only relevant pending issues and that may unfold over the coming weeks are: (i) the third quarter of 2015 earnings release, which is scheduled for November 5, 2015; and (ii) the possible completion of the joint venture between the Company and Cielo S.A. (BM&FBovespa: CIEL3; OTC: CIOXY), which still depends of the conclusion of the negotiations between both companies, which remain ongoing, the signing of the definitive agreements by both parties and the approval of the joint venture by the competent regulatory authorities, as disclosed in the material fact of June 2, 2014.

The Company will keep its shareholders and the market informed of any relevant act or fact related to its business.

Click here to access the full notice


IR CONTACT:

Dennis Herszkowicz
Finance VP and Investor Relations Officer

Alexandre Kelemen 
Investor Relations
+55 11 2103-1575
ir@linx.com.br


Telephone: (11) 2103-1575

E-mail: ir@linx.com.br

Website: www.linx.com.br/ri